Maximum Dose of Gliclazide Modified Release
The maximum recommended dose of gliclazide modified release (MR) is 120 mg once daily 1, 2, 3, 4, 5.
Dosing Algorithm
Starting dose: 30 mg once daily
Titration schedule:
- Increase by 30 mg increments at monthly intervals
- Titrate based on fasting plasma glucose (target ≤7.7 mmol/L) and HbA1c goals
- Maximum dose: 120 mg once daily
The dose should be taken once daily, which can be administered without regard to meals, improving patient compliance compared to twice-daily formulations.
Evidence Base
Multiple clinical trials consistently demonstrate that gliclazide MR is dosed from 30-120 mg once daily 1, 2, 3, 4, 5. The EASYDia trial, a large real-world study of 7,170 patients across eight countries, used this dosing range and achieved clinically significant HbA1c reductions of -1.78% across all baseline HbA1c strata 2. The GUIDE study, comparing gliclazide MR to glimepiride, also used the 30-120 mg daily range and demonstrated equivalent efficacy with significantly better safety (50% fewer hypoglycemic episodes) 4.
A pharmacometric modeling study in 2023 suggested that the MR formulation could potentially be increased to 270 mg for maximum efficacy without exceeding hypoglycemia risk of the immediate-release formulation 1. However, this remains investigational and is not part of current clinical practice or approved labeling.
Safety Profile
At the maximum dose of 120 mg daily:
- Severe hypoglycemia requiring external assistance is rare (0.06% in the EASYDia trial) 2
- Confirmed hypoglycemia (blood glucose <3 mmol/L) occurs in approximately 3.7% of patients 4
- The safety profile remains favorable even in elderly patients and those with impaired renal function 5
Clinical Pearls
- The once-daily formulation uses a hydrophilic matrix polymer that provides progressive drug release over 24 hours, matching the glycemic profile
- Weight loss is typically observed when baseline BMI ≥25 kg/m² 2
- Patients with highest baseline HbA1c experience the greatest improvements
- No dose adjustment is specifically required for elderly patients, though monitoring remains important